0000899243-19-025027.txt : 20191003 0000899243-19-025027.hdr.sgml : 20191003 20191003204022 ACCESSION NUMBER: 0000899243-19-025027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191001 FILED AS OF DATE: 20191003 DATE AS OF CHANGE: 20191003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Revesz Tomas Jr CENTRAL INDEX KEY: 0001744802 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38549 FILM NUMBER: 191137338 MAIL ADDRESS: STREET 1: 210 BROADWAY CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EverQuote, Inc. CENTRAL INDEX KEY: 0001640428 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 263101161 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 BROADWAY CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-245-0615 MAIL ADDRESS: STREET 1: 210 BROADWAY CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-10-01 0 0001640428 EverQuote, Inc. EVER 0001744802 Revesz Tomas Jr C/O EVERQUOTE, INC. 210 BROADWAY CAMBRIDGE MA 02139 0 1 0 0 Chief Technology Officer Class A Common Stock 2019-10-01 4 S 0 7907 20.88 D 617093 D Class A Common Stock 2019-10-01 4 S 0 5000 20.88 D 612093 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2019. The sales do not represent a discretionary trade by the reporting person. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2019 and represent the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 28, 2019. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.24 to $21.46, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. /s/ David Mason, as attorney-in-fact for Tomas Revesz 2019-10-03